Navigation Links
New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis
Date:9/3/2008

The American College of Rheumatology Research and Education Foundation's

Within Our Reach Campaign Yields Significant Advances in Detecting,

Treating and Understanding RA

ATLANTA, Sept. 3 /PRNewswire/ -- For the first time during its unprecedented initiative to find a cure for rheumatoid arthritis, the American College of Rheumatology Research and Education Foundation is releasing new information acquired from research funded by the Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign.

Doctors and scientists from across the nation are utilizing more than $12 million in grants awarded by the ACR REF to investigate critical issues including early detection of RA, novel treatment pathways as well as improved patient-provider interaction and patient care. While research is still underway, the REF is encouraged by the progress made thus far and is pleased to announce the new and promising knowledge which RA researchers will continue to build upon as studies continue.

"The REF is committed to funding RA research that is not being done elsewhere, and supporting scientists and doctors who are most prepared and motivated to work on finding a cure," said Dr. Leslie J. Crofford, president of the REF. "The quality and value of the studies in progress is evidence that the Within Our Reach campaign to is critical and must continue."

Viewed as one of the most disabling types of arthritis, RA affects nearly 1.3 million Americans. But, because of rapidly advancing research into the fundamentals of inflammation, the outlook for those suffering from RA has improved dramatically over the past 25 years. Recent advances in treatment have made it possible to stop, or at least slow the progression of joint damage. Additionally, new therapies that target inflammation are being developed.

Today the Within our Reach campaign is supporting 30 innovative research studies and highlights of new information gained
'/>"/>

SOURCE ACR Research and Education Foundation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
5. Video: New Research Discovers Independent Brain Networks Control Human Walking
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
11. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...re/ -- Facet Solutions, Inc. announced today that ...edics. The acquisition creates an undisputed leade...property and clinical experience in posterior moti...ring from lumbar spinal stenosis," stated Facet So...consolidation further strengthens Facet Solutions,...
(Date:11/6/2009)...re/ -- Philips Respironics applauds the efforts of...DC) to raise awareness about an important public h...C,s release of the first-ever government study to ...s is a milestone in quantifying the size and scope...ndustry leader and sleep therapy manufacturer, Phi...
(Date:11/6/2009)... 6 Chimerix, Inc., a biopharmaceut...therapeutics to address life-threatening diseases,...ny,s lead antiviral compound, CMX001, to the World...ecurity Initiative (GHSI). CMX001 is a broad-spec...ment of smallpox, as well as other serious viral i...
Breaking Medicine Technology:Facet Solutions Acquires Archus Orthopedics 2Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 1Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 2Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 3Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 4Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City 13311 1Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City 13311 2Partnership for Prescription Assistance Prepared to Help New York Workers Hurt by Recession 53371 1Partnership for Prescription Assistance Prepared to Help New York Workers Hurt by Recession 53371 2Partnership for Prescription Assistance Prepared to Help New York Workers Hurt by Recession 53371 3
...ed Alone and in Combination with Chemotherapy, FR..., a,development-stage pharmaceutical company disco...)-based therapeutics, today announced that the,jou... of siRNA targeting,its proprietary target gene ag...ition dated October 1, 2008. The paper, entitled "...
...ASHINGTON, Oct. 12 Boston,Scientific Corporation ...ysis,of nearly 7,500 patients from its TAXUS ARRIV...m the performance of the TAXUS(R) Express2(TM),Pac...d practice. The,two-year pooled ARRIVE data showed...in patients with diabetes as effectively as in pat...
Other Medicine Technology:Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 2Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 3Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5
(Date:11/8/2009)...ire/ -- Speaker Nancy Pelosi and Democratic leader...age of H.R. 3962, the Affordable Health Care for A...15. Below are the Speaker,s opening remarks: ,...ll from the President of the United States, Barack...he American people. I thank the President for his ...
(Date:11/8/2009)...s is pleased to announce that it has been successf...ound who recently received an award on the $800 mi...ncludes not only the Veterans Administration, but ...gencies. , New York, NY (...pleased to announce that it has been successful in...
(Date:11/8/2009)... in the Western District of Pennsylvania award a F...ng for a medical malpractice case. Attorneys Thom...mas E. Crenney and Associates, LLC handled the cas... against the Uniontown Hospital. The woman had to... age 18. , Pittsburgh, PA...
(Date:11/8/2009)...health advocates committed to achieving meaningful.... 7 "Tonight the U.S. H... voice of America,s families by passing the Afford...ust deliver, without delay, on the promise of mean...do, President and CEO of the National Alliance for...
(Date:11/8/2009)...to Secure the Stability of Medicare ,, HOUSTON...ibutable to: J. James Rohack, M.D., President, Ame...ww.newscom.com/cgi-bin/prnh/20081209/AMALOGO ) ,...h reform bill, which will help improve the health ...wift passage of H.R. 3961 to secure the stability ...
Breaking Medicine News(10 mins):Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2
... ‘present’ - the common cause of amnesia, also pre...ing them to live only in the present. Researc...f Proceedings of the National Academy of Sciences ...rucial in learning and memory. Though, it has...
...bout having a child, it’s a research they will bac...ospital plan the first uterus transplant with the ...medical adventure is not without ethical controve...ient gives birth so she would not need anti-reject...
...alia health providers is busy counting its losses....ve had their doctors resort to rorting or over ser...procedures that were not necessary. The loss in...s at inappropriate practices such as over-servicin...
...rge family may not be best for your health. A new ...e development of stomach cancer linked to the bact...from large families appeared to be especially vuln...re followed over a 28-year period. The researchers...
...d a structural protein called nestin to a particul...ew biomarker that could lead to earlier detection ...sue of Cancer Research, researchers from Dartmouth...ith similarities to mammary stem cells, the regene...
...ening of adults age 50 or older appears to be as c...er screening programs, according to an article in ... Melanoma is the only cancer for which incidence...cle. Treating melanoma costs more than $740 millio...
Other Medicine News:Health News:Amnesia Halts Future Thinking: Study 2Health News:Uterus Transplant- A Future Reality 2Health News:Link Between Family Size and Stomach Cancer Found 2Health News:Link Between Family Size and Stomach Cancer Found 3Health News:Selective Marker Found to Indicate Aggressive Form of Breast Cancer 2Health News:Selective Marker Found to Indicate Aggressive Form of Breast Cancer 3Health News:One-time Melanoma Screening Appears to Be Cost-effective for Elderly People 2
OHL Periosteal Elevator
Steinhauser Periosteal Elevator
Dolwick-Reich Condyle Periosteal Elevator
Molt Periosteal Elevator
Medicine Products: